Drug intelligence / Profile preview

Escherichia coli Bacterin

Development stage
Unknown
Lead developer
Hygieia Biological Laboratories
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Escherichia coli Bacterin is an inactivated bacterial vaccine developed by Hygieia Biological Laboratories for use in veterinary medicine, specifically for dairy and beef cattle. As a bacterin, it contains killed *Escherichia coli* bacteria that serve as antigens to stimulate the animal's immune system, inducing an adaptive immune response. This vaccine is designed to prevent or reduce the severity of infections caused by *E. coli*, such as coliform mastitis in dairy cows and neonatal diarrhea (scours) in calves. Hygieia Biological Laboratories specializes in tailored veterinary biologics, and this product is part of their portfolio of agricultural animal health solutions.

Brand names
E. coli Bacterin
Other names
Escherichia coli vaccineInactivated Escherichia coli vaccine

Beyond the preview

Go deeper on Escherichia coli Bacterin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli Bacterin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call